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Abstract:
ABSTRACT 
Background: Long-term opioid therapy (> than 12 months) is not 
effective for improving chronic non-cancer pain and function. Where 
patients are not experiencing pain relief with long-term opioids, the 
opioid should be tapered and discontinuation considered. Practitioners 
may find it challenging to tell patients experiencing pain that they are 
better off reducing or not taking medicines that do not help. This review 
aims to ascertain what is published about: (1) the interaction and (2) the 
nature of the relationship between practitioners and patients when 
prescribing opioids for chronic non-cancer pain in primary care. 
Method: A scoping review of English language qualitative, quantitative or 
mixed method studies in databases including: MEDLINE, Embase, 
PsycINFO, AMED, BNI, CINALH EMCARE and HMIC.  The identified papers 
were reviewed to provide a descriptive summary of the literature. 
Results: The review identified 20 studies. The studies used a range of 
methods including interviews, focus groups, audio and video recordings 
of clinical consultations, telephone survey and data from patient records. 
One study reported that researchers had engaged with a patient 
advisory group to guide their research. 
Patients expressed the importance of being treated as individuals, not 
being judged and being involved in prescribing decisions. Practitioners 
expressed difficulty in managing patient expectations and establishing 
trust. Opioid risk and practitioner suspicion shape opioid prescribing 
decisions. 
There is a paucity of literature about how precisely practitioners 
overcome interactional challenges and implement personalised care in 
practice. 
Conclusion: The studies in this review ascertain that practitioners and 
patients often find it challenging to achieve shared decisions in opioid 
review consultations. Effective communication is essential to achieving 
good clinical practice. Collaborative research with PPI partners should be 
aimed at identifying communication practices that support practitioners 
to achieve shared decisions with patients when reviewing opioids for 
chronic non-cancer pain. 
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Background: Long-term opioid therapy (> than 12 months) is not effective for improving 
chronic non-cancer pain and function. Where patients are not experiencing pain relief with 
long-term opioids, the opioid should be tapered and discontinuation considered. Practitioners 
may find it challenging to tell patients experiencing pain that they are better off reducing or 
not taking medicines that do not help. This review aims to ascertain what is published about: 
(1) the interaction and (2) the nature of the relationship between practitioners and patients 
when prescribing opioids for chronic non-cancer pain in primary care. 
Method: A scoping review of English language qualitative, quantitative or mixed method 
studies in databases including: MEDLINE, Embase, PsycINFO, AMED, BNI, CINALH 
EMCARE and HMIC.  The identified papers were reviewed to provide a descriptive summary 
of the literature. 
Results: The review identified 20 studies. The studies used a range of methods including 
interviews, focus groups, audio and video recordings of clinical consultations, telephone 
survey and data from patient records. One study reported that researchers had engaged 
with a patient advisory group to guide their research.
Patients expressed the importance of being treated as individuals, not being judged and 
being involved in prescribing decisions. Practitioners expressed difficulty in managing patient 
expectations and establishing trust. Opioid risk and practitioner suspicion shape opioid 
prescribing decisions.
There is a paucity of literature about how precisely practitioners overcome interactional 
challenges and implement personalised care in practice.
Conclusion: The studies in this review ascertain that practitioners and patients often find it 
challenging to achieve shared decisions in opioid review consultations. Effective 
communication is essential to achieving good clinical practice. Collaborative research with 
PPI partners should be aimed at identifying communication practices that support 
practitioners to achieve shared decisions with patients when reviewing opioids for chronic 
non-cancer pain. 
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Chronic non-cancer pain (CNCP) lasts more than three months and includes numerous pain 
conditions: lower back pain, musculoskeletal pain, abdominal pain, headache and 
neuropathic pain1.
The prevalence of CNCP in UK adults varies from 35% to 50% with moderately severe pain 
and disabling pain prevalence being 10% to 14%2. Back pain alone accounts for 40% of 
sickness absences in the NHS3. Patients with CNCP consult their GPs up to five times more 
frequently than other patients4 and chronic pain is the presenting condition in around a fifth of 
primary care consultations4.
Long-term opioid medicines
Opioids are effective analgesics for acute pain and pain at the end of life but there is limited 
evidence supporting long-term prescribing to manage CNCP5. The risks of long-term use 
may outweigh any benefits. A review of the effectiveness and risks of long-term opioid 
prescribing (> 3 months) did not find any studies comparing opioid versus placebo or non-
opioid therapy researching outcomes beyond 12 months6. It concluded that there was 
insufficient evidence to determine the effectiveness of long-term opioid therapy for improving 
CNCP and function. It also highlighted that dose dependent risks are associated with the use 
of long-term opioids including overdose, opioid abuse and fractures6. Further to this, a 
pragmatic randomised trial comparing opioid versus non-opioid medicines; found opioids 
were not superior to treatment with non-opioids for improving pain-related function over 12 
months7. In an epidemiological study comparing patients using opioids and non-opioids for 
CNCP, long-term use of opioids was significantly associated with reporting of moderate to 
severe pain, poor self-rated health, higher use of the health care system, and a negative 
influence on quality of life8. The cross-sectional nature of this study means that causal 
relationships cannot be drawn. However, it is important to note that long-term opioid 
treatment did not meet any of the key outcomes related to successfully treating CNCP.
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The majority of prescribing opioid medicines in the UK takes place in primary care through 
General Practices (GPs). Despite the lack of research evidence for the effectiveness of long-
term opioids in the management of CNCP, an analysis of prescribing data shows a 
substantial increase in prescribing practice between 1998 and 20169. In 2016, 776 opioid 
prescriptions were dispensed per 1000 patients9. A longitudinal analysis (between 2005 and 
2012) of prescribing opioids in general practice showed the number of patients prescribed a 
weak opioid at least once almost doubled from 6.5% to 12.4%10 and the number of patients 
prescribed a strong opioid at least once increased by more than six fold from 0.13% to 
0.85%10.
In relation to the duration for which opioids are being prescribed, between 2005 and 2012 
approximately 5% of patients per GP practice were being prescribed a long-term opioid and 
1% of patients were being prescribed a long-term strong opioid10. These findings were 
echoed in a population based study of 49,999 patients using the Clinical Practice Research 
Datalink11. This study showed that in 2014, 5.2% of the study population were prescribed 
opioids and about 34% of opioid patients were receiving a prescription for more than 30 days 
duration11. More recently Ashye and colleagues reported that about 40% of the 703 
participants in their study received more than 3 opioid prescriptions a year12.
National guidance
The National Institute of Health and Care Excellence (NICE) and the Faculty of Pain 
Medicine (FPM) recommend that where patients are not experiencing relief from pain with 
long-term opioid medicines they should be encouraged and supported to reduce and stop 
the opioid if possible13,14. Practitioners may find it challenging to discuss with patients 
experiencing intolerable pain that they are better off reducing or not taking medicines that do 
not help, particularly if there is no therapeutic alternative15. The aims of this review are to 
ascertain what is published about: (1) the interaction and (2) the nature of the relationship 
between practitioners and patients when prescribing opioids for CNCP in primary care.
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This review takes the form of a scoping review. It follows guidance set out in the Joanna 
Briggs Institute (JBI) manual for reviewers16 and is reported using the PRISMA preferred 
reporting items for systematic reviews and meta-analyses extension for scoping reviews 




Adults over the age of 18 years prescribed an opioid for CNCP.
Context of the study
Decision making when prescribing opioids for CNCP can be influenced by factors relating to 
the patient, the consultation, experiences and perceptions of the patient and prescriber as 
well as the healthcare system in which the prescribing takes place. This scoping review will 
focus on prescribing by any healthcare practitioner (doctor, pharmacist, nurse) in a primary 
care setting.
Phenomena of interest
Studies were included if they document the interaction and relationship between 
practitioners and patients relating to prescribing opioids for CNCP. 
Types of studies 
Studies published in English language using qualitative, mixed-method or quantitative 
methods were included. Systematic reviews and meta-synthesis were also included. 
Reference lists of identified systematic reviews were reviewed for studies that may not have 
been highlighted in the initial search. Conference abstracts or presentations, thesis and 
dissertations were excluded due to the amount of detail that is usual to these texts (e.g. 
restricted word count associated with abstracts and substantial word count associated with 
thesis and dissertations). 
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Initially a search was conducted on Embase to help identify and refine search terms. Search 
terms from known existing literature were used to help support this process. A full search 
using the identified terms was conducted using MEDLINE, Embase, PsycINFO, AMED, BNI, 
CINALH EMCARE and HMIC. All databases were searched from inception. The search was 
completed on 11th June 2020. The full search strategy is detailed in Appendix 2. 
Data collection
The studies identified for inclusion were reviewed independently by two reviewers at each 
stage of the review process: title screening, abstract screening and full paper review. 
Reviewers recorded their decisions. Discrepancies between reviewers were documented 
and discussed with the review team so that an outcome could be achieved. 
Assessment of included studies
The JBI reviewer’s manual recommends that scoping reviews should aim to provide an 
overview of the existing evidence regardless of quality16. Individual studies were therefore 
not methodologically assessed for quality. A charting table was developed to record the 
relevant information from each study, this included: author(s), publication year, country 
where the study was conducted, aims and objectives of the study, the population being 
studied, sample size (if applicable), methodology / design / methods and findings related to 
the scoping review question. This was done iteratively with the review team giving feedback 
on the data charted so as to provide a logical and descriptive summary of the included 
studies that aligns with the aims of the scoping review.
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Twenty studies were included in the review. A flow diagram illustrating the number of studies 
that were included and excluded at each stage is in figure 1.
Figure 1: PRISMA flow diagram illustrating the search strategy results
Records identified through database 
search n = 16,428
Records after duplicates removed n = 
10,827
Titles screened n = 10,827
Abstracts screened n = 254
Full text articles reviewed n = 35
Studies included in analysis n = 20
Records excluded n = 
10,573
Records excluded n = 219
Did not explore 
relationships n = 5
Cancer pain n = 1
Not in primary care n = 2
Unable to access n = 1
Abstracts only n = 6
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Description of the included studies
All of the studies included involved patients and practitioners prescribed or prescribing 
opioids for CNCP in primary care. Sixteen studies were undertaken in the United States of 
America (USA)17-32, two were performed in the United Kingdom (UK)33,34 and one was based 
in Canada35. 
One of the included studies is a meta-synthesis36. Some of the studies included in the meta-
synthesis17-20,22,33 are also included in this review. The rationale for including the meta-
synthesis in this review is to incorporate the authors’ theorised perspective of the 
practitioner-patient relationship.
One study reported that researchers had engaged with a patient advisory group to guide 
their research28.
A descriptive summary of the studies and the key findings related to the review aims is 
presented in Appendix 3.
Aims of the studies in the review
Three studies aimed to understand patient perspectives / experience of opioid 
prescribing21,26,27. Practitioner perspectives / experience of opioid prescribing, was the aim of 
three further studies22,29,35 as well as the meta-synthesis36. Both patient and practitioner 
perspectives / experience of opioid prescribing was the aim in two studies17,18.
Two studies explored practitioner and patient trust when prescribing opioids19,28, whilst a 
further four studies explored understanding communication between practitioners and 
patients20,24,30,31. Three studies examined the decision making process23,25,32. 
One study aimed to understand how problematic long-term opioid prescribing becomes 
established33 and another assessed the acceptability of a pain review service34. 
Population studied
All of the studies included patients and practitioners with an experience of prescribed opioids 
for CNCP. CNCP included all non-cancer pain, however in six of the studies this was limited 
to musculoskeletal pain20,23-25,30,31. Three studies included practitioners that were from 
several disciplines (doctors, nurses, clinical pharmacists)22,29,34. 
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Methods for data collection
The included studies used a range of methods to explore the practitioner and patient 
relationship. Six of the studies used interviews17,18,22,26,34,35 and five of the studies used both 
interviews and focus groups19,21,27,29,33. Six studies used recordings of clinical consultations, 
with four using an audio recording20,23,25,30  and two using video recording24,31. One study 
collected data from reviewing patient records32 and one study used a telephone survey of 
patients28.
Methods for data analysis
The studies using data from interviews and focus groups used a variety of methods for data 
analysis. Thematic analysis17,22,27,34 or grounded theory19,21,33 were the most used 
approaches. The theoretical domains framework35, immersion and crystalisation18, mixed 
deductive and inductive26,29 approaches were also used by researchers. Thematic analysis 
was also used to analyse data in the one study reviewing medical records32. Those studies 
using audio or video recordings to collect data used immersion and crystalisation20 and 
constant comparison25,30 as qualitative approaches to analyse data. However quantitative 
approaches using statistical analysis of coded data were also used in four studies23,24,28,31. 
One study used a list of coded communication measures to relate practitioner and patient 
characteristics to communication23, whilst another study coded data from videotaped 
practitioner and patient consultations and then related these codes to the patient and 
practitioner experience of the consultation24. A further study used coded assessments of 
patient statements. Assessments were coded as positive, negative or ambivalent and were 
compared with practitioner responses to these statements31. In the study using a telephone 
survey, the researchers provided raw counts for responses to questions about trust, such as 
“I feel my doctor trusts me in how I manage my opioid pain medicine”. Results were adjusted 
for potential bias due to non-respondents28. 
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Findings related to the review question 
Interaction between practitioners and patients when making decisions about prescribed 
opioids for CNCP
Discussions about opioids were directed by pressure from guidance25,27, greater patient pain 
catastrophisation23 or where practitioners were orientated towards psychosocial 
interventions23. Practitioner and patient disagreement25,33,36,32 along with requests for an 
increase in opioid dose were associated with significantly worse experience of 
consultations24. Negative interactions happen where decisions were taken unilaterally by the 
practitioner27,30,32,  or where the stigma associated with prescribing opioids resulted in a 
reluctance to prescribe and interrogation of the patient18,19,21. Some patients prescribed 
opioids describe not being treated as individuals17, being judged18,21,26 and not feeling that 
they are involved in the decision making process25,30,34. Patients valued the importance of 
being listened to20,25,34 especially where practitioners have taken the time to build a 
supportive relationship with the patient22,27,34 and where they experience a degree of 
interpersonal assurance19. 
Nature of the relationship between patients and practitioners when prescribing opioids for 
CNCP
Establishing mutual trust lays the foundation to successful pain management17. One study 
reported a high degree of trust between practitioners and patients28. However, others 
reported that practitioners find it difficult to establish trust with patients when there is a 
difference in understanding of pain18,33 or if they are uncertain about the patients’ account of 
pain19,29. The subjective nature of pain alongside inconsistencies between diagnosis and the 
patients’ experience contribute to compromising trust22. This may lead to practitioners 
forming fixed negative attitudes towards patients33 and miss opportunities where review of 
opioids can be explored31.
Practitioners report difficulty in managing patient expectation22, experiencing stress and 
reduced job satisfaction as a result of challenging conversations about opioids22,29,35. When 
prescribing opioids there is a tension between managing pain and facilitating opioid misuse35 
as well as a tension between keeping the patient satisfied and safe use of prescribed 
opioids25,29. This can compromise the therapeutic alliance. A systematic meta-synthesis of 
practitioner perceptions theorised that opioid risk and practitioner suspicion shape opioid 
prescribing decisions36. 
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The studies exploring communication20,24,30,31 or decision making 23,25,32 between practitioners 
and patients used audio recording of clinical consultations20,23,25,30, video recording of clinical 
consultations24,31 and review of patient clinical records32 to conduct their research. 
Data was analysed qualitatively in four studies20,25,30,32. Whilst this design gives practitioner 
and patient insights into communicative practice and decision making in clinical practice, it 
misses how utterances and non-verbal cues from practitioners impact on the patient in real 
time37 and hence misses precisely how practitioners achieve collaboration with patients in 
clinical consultations. 
Video recording of clinical consultations captures both verbal and non-verbal communicative 
clues38 to identify important insights about clinical practice38. Of the two studies that used this 
method, both used associations between coded data and interactional behaviours to identify 
communicative practice24,31. Coding relies on the researchers’ preconceived theoretical 
concept of the consultation, this may uncover key aspects of communicative practice in 
consultations, but may also miss new or relevant interactional practice39,40 that practitioners 
use to achieve collaboration with patients. 
DISCUSSION
This review identifies that practitioners and patients face interactional challenges when 
making decisions about prescribing long-term opioids for CNCP. This can compromise the 
therapeutic alliance in a clinical relationship.
Medicines optimisation (MO) ensures patients get the right choice of medicine, at the right 
time, and are engaged in the process by practitioners41. MO should follow the principles of 
shared decision making where patients are empowered to be involved in decisions about 
their health. Individuals and clinicians should work together to understand the treatment 
options that are most appropriate, bearing in mind the person’s individual circumstances42. 
Effective practitioner-patient communication is a central clinical function in building a 
therapeutic relationship43. The importance of communication has been highlighted in practice 
guidelines. The role of effective communication in improving patient care is underlined by the 
Personalised Care Institute44. It has also highlighted in NICE and FPM guidance for 
assessing and managing pain13,14. A review of clinician and patient communication identified 
improved practitioner-patient communication tends to increase patient involvement in 
managing their condition; influence patient satisfaction, adherence, and health care 
utilization; and improve quality of care and health outcomes43. 
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One study in this review reported on Patient and Public Involvement (PPI) to guide research 
about trust between practitioner and patient when prescribing opioids for CNCP28. Patient 
partners as lived experience based experts contribute knowledge that is complementary to 
that of researchers and professionals. Their input into the design, conduct and dissemination 
of research has been shown to improve the quality, relevance and uptake of research46. The 
National Institute for Health Research recommends that PPI input should be embedded in 
practice so that researchers naturally take on the values and practices of effective public 
involvement47.
This review ascertains that there is a paucity of literature about how precisely practitioners 
overcome interactional challenges that might present when reviewing opioids and implement 
personalised care in practice. It also highlights a lack of published research conducted with 
PPI partners. Further collaborative study of practitioner and patient interaction using 
methods such as conversation analysis, which analyse the structure of communication, will 
provide new insights into how communication is co-constructed between practitioner and 
patient40.  This can then be used to identify communicative practice that help enact trust, 
achieve therapeutic alliance and give an insight into what good communicative practice 
looks like in routine primary care encounters37,40.
Strengths and weakness
This study was conducted in line with the JBI guidelines following a systematic process. A 
predefined review protocol was agreed prior to commencement. Two reviewers 
independently assessed studies at each stage of the process. Data extraction was 
completed using a standardised spread-sheet by the lead reviewer. An independent patient 
and public involvement partner, with lived experience of CNCP has reviewed this paper and 
suggested comments on the findings.
Studies may have been missed due to the search terms used in the review. The studies 
included have not been assessed for quality and reflect a high degree of heterogeneity with 
regard to method and theoretical stance. The majority of studies are based in the USA. This 
may present a bias as the interaction and nature of relationship between practitioners and 
patients will reflect the health system within which they operate. This review intends to make 
comment on the state of current literature on the interaction between practitioners and 
patients when prescribing opioids for CNCP and identify gaps for further research. 
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 Researchers with PPI partners should consider a systematic review of literature to 
identify communication practices that support collaborative care with patients 
prescribed opioids for CNCP.
 Researchers with PPI partners should consider further examination of video recorded 
clinical consultations and identify communication practices that support collaborative 
care with patients prescribed opioids for CNCP.
 A consensus process is needed to depict best practice and provide guidance on 
communication practices that help support collaborative care with patients prescribed 
opioids for CNCP. 
CONCLUSION
The studies in this review ascertain that practitioners and patients often find it challenging to 
achieve shared decisions in opioid review consultations. Effective communication is 
essential to achieving good clinical practice. Collaborative research with PPI partners should 
be aimed at identifying communication practices that support practitioners to achieve 
personalised care with patients when reviewing opioids for CNCP.
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Figure 1: PRISMA flow diagram illustrating the search strategy results
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Collaboration between practitioners and patients when making decisions about 
prescribing opioids for chronic non-cancer pain in primary care – A scoping review
Aim
 To identify what research literature exists on the contexts of the interaction between 
patients and practitioners and factors that influence opioid use and prescribing.
 To identify what research literature exists on the nature of the relationship between 
patients and practitioners when prescribing opioid medicines.
Types of studies to be included:  
 Research papers that document the relationship between practitioners and patients 
relating to prescribing opioid medicines for chronic non-cancer pain in a primary care 
setting
 Research papers published in a peer-reviewed journal
 Research papers using a quantitative, qualitative or mixed-method approach 
Exclusion criteria
Non-English language papers, policy documents, conference abstracts or presentations and 
study protocols will be excluded. 
Search strategy
Databases to be searched
MEDLINE, Embase, PsycINFO, AMED, BNI, CINALH EMCARE, HMIC from imception
Search terms
(((exp CONVERSATION/ OR exp "PROFESSIONAL-PATIENT RELATIONSHIP"/ OR exp 
"PATIENT ATTITUDE"/ OR exp "HEALTH PERSONNEL ATTITUDE"/ OR exp "GENERAL 
PRACTICE"/ OR “Primary care”/ OR (communication*).ti.ab OR (patient*).ti,ab OR 
(attitude*).ti,ab OR (interaction*).ti,ab OR (relationship*).ti,ab OR (communication*) ti.ab OR 
(primary healthcare).ti,ab OR (GP*).ti,ab OR (physician*).ti,ab OR (doctor*).ti,ab OR 
(clinician*).ti,ab OR (practitioner*).ti,ab OR (pharmacist*).ti.ab OR (nurse*).ti.ab 
AND
 ((chronic pain).ti,ab OR exp "CHRONIC PAIN"/ OR (chronic non-cancer pain).ti,ab OR 
(chronic non cancer pain).ti,ab)) 
AND 
((tramadol).ti,ab OR (hydromorphone).ti,ab OR (fentanyl).ti.ab OR (pethidine).ti,ab OR 
(dihydrocodeine).ti,ab OR (oxycodone).ti,ab OR (hydrocodone).ti,ab OR (oxymorphone).ti,ab 
OR (morphine).ti,ab OR (codeine).ti,ab OR (meptazinol).ti,ab OR (buprenorphine).ti,ab OR 
(diamorphine).ti.ab. OR (dipipanone).ti.ab OR (meperidine).ti.ab. OR (papaveretum).ti.ab. 
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OR (opiate*).ti,ab OR (opioid*).ti,ab OR exp "NARCOTIC ANALGESIC AGENT"/ OR exp 
"MORPHINE DERIVATIVE"/)) 
[English language] [Human age groups Adult 18 to 64 years OR Aged 65+ years]
Study selection
Following removal of duplicate citations, retrieved titles and abstracts will be screened for 
inclusion by two reviewers working independently, and disagreements will be resolved by 
discussion with the wider scoping review team.
Data extraction
A charting table or form will be developed to record the key information of the source, this 
will include:
 Author(s)
 Year of publication
 Origin/country of origin (where the study was published or conducted)
 Aims/purpose
 Study population and sample size (if applicable)
 Methodology / Design / Methods
 Key findings
 How findings relate to the scoping review question/s.
This process will provide a logical and descriptive summary of the results that aligns with the 
objective/s and question/s of the scoping review
A reviewer will chart each study, the charting process will be an iterative process, and it may 
become apparent that additional unforeseen data can be usefully charted. The review team 
will feedback on charting of two or three studies to ensure all relevant results are extracted.
Presentation of the results
The results of a scoping review will be presented as a chart of the data extracted from the 
included papers and in a descriptive format that aligns with the aims / objectives and scope 
of the review. 
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Databases to be searched
MEDLINE, Embase, PsycINFO, AMED, BNI, CINALH EMCARE, HMIC from 
imception
Search terms
(((exp CONVERSATION/ OR exp "PROFESSIONAL-PATIENT RELATIONSHIP"/ 
OR exp "PATIENT ATTITUDE"/ OR exp "HEALTH PERSONNEL ATTITUDE"/ OR 
exp "GENERAL PRACTICE"/ OR “Primary care”/ OR (communication*).ti.ab OR 
(patient*).ti,ab OR (attitude*).ti,ab OR (interaction*).ti,ab OR (relationship*).ti,ab OR 
(communication*) ti.ab OR (primary healthcare).ti,ab OR (GP*).ti,ab OR 
(physician*).ti,ab OR (doctor*).ti,ab OR (clinician*).ti,ab OR (practitioner*).ti,ab OR 
(pharmacist*).ti.ab OR (nurse*).ti.ab 
AND
 ((chronic pain).ti,ab OR exp "CHRONIC PAIN"/ OR (chronic non-cancer pain).ti,ab 
OR (chronic non cancer pain).ti,ab)) 
AND 
((tramadol).ti,ab OR (hydromorphone).ti,ab OR (fentanyl).ti.ab OR (pethidine).ti,ab 
OR (dihydrocodeine).ti,ab OR (oxycodone).ti,ab OR (hydrocodone).ti,ab OR 
(oxymorphone).ti,ab OR (morphine).ti,ab OR (codeine).ti,ab OR (meptazinol).ti,ab 
OR (buprenorphine).ti,ab OR (diamorphine).ti.ab. OR (dipipanone).ti.ab OR 
(meperidine).ti.ab. OR (papaveretum).ti.ab. OR (opiate*).ti,ab OR (opioid*).ti,ab OR 
exp "NARCOTIC ANALGESIC AGENT"/ OR exp "MORPHINE DERIVATIVE"/)) 
[English language] [Human age groups Adult 18 to 64 years OR Aged 65+ years]
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Chart describing study characteristics
STUDIES EXPLORING PATIENT PERSPECTICES OF PRESCRIBING OPIOIDS FOR CNCP
No Authors Year Country Aims Population Design / method Key findings
1 Wallace, L. Wexler, R. 
McDougle, L. Miser, F. 
Haddox, D. 
2014 USA To comprehensively define the 
chronic pain experience from the 
patients perspective. 
Patients receiving 
opioid medicines for 
chronic non-cancer 
pain within one 
medical centre.
One to one interviews with 25 
patients using photovoice 
method. Followed by focus 
group discussions about 
displayed photographs.  
Grounded theory approach 
was used to analyse data. 
Patient perspective:
 Physicians did not understand 
patients’ feelings towards taking 
opioid medicines; they just assumed it 
was all about seeking out more 
prescriptions. 
2 Frank, J. Levy, C. 
Matlock, D. 
Calcaterra, S. Mueller, 
S. Koester, S. 
Binswanger, I. 
2016 USA To understand patients 
perspectives of opioid tapering. 
Patients within primary 
care clinics prescribed 
opioid medicines for 
chronic non-cancer 
pain. 
Health belief model, social 
cognitive theory and the trans 
theoretical model. Semi-
structured interviews with 24 
patients. Analysis using a 
mixed deductive and inductive 
approach. 
Patient perspective:
 A trusted provider that is supportive, 
flexible, non-judgmental and 
accessible is important to initiating 
and sustaining opioid tapering.  
3 Henry, S. Paterniti, D. 
Feng, B. Losif, A. 
Kravitz, R. Weinberg, 
G. Cowan, P. Verba, 
S. 
2018 USA Insight into the patient 
experience with opioid tapering
Patients registered in 
primary care clinics 
with neck or back pain 
prescribed long term 
opioid medicines for 
longer than 3 months
21 patients in four focus 
groups. 7 patients with face to 
face interviews. Iterative 
review of transcripts leading to 
themes of accounts relating to 
tapering opioids. Themes 
summarised to develop 
conceptual model of patients’ 
tapering experience. 
Patient perspective:
 Positive interactions where clinicians 
took time to understand patient needs 
build mutual trust, devise individual 
tapering plans. 
 Negative interaction where unilaterally 
stopped or tapered opioids leaving 
patients with a profound sense of loss 
and betrayal.
 Clinicians not being honest and 
motivated by institutional pressure.
 Patients reluctant to challenge 
clinicians for fear of losing medical 
services
 Importance of mutual honesty 
between patients and clinicians. 
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STUDIES EXPLORING PRACTITIONER PERSPECTIVES OF PRESCRIBING OPIOIDS FOR CNCP
No Authors Year Country Aims Population Design / method Key findings
4 Matthias, M. Parpart, 
A. Nyland, K. 
Huffman, M. Stubbs, 
D. Sargent, C. Bair, M. 
2010 USA To understand primary care 
provider perspectives of chronic 
pain




interviews with 20 primary 
care providers. Thematic 
analysis of data. 
Practitioner perspective:
 Developing strong relationships with 
patients enhances trust. 
 Difficulties in managing patient 
expectation, especially when 
prescribing opioids. 
 Subjective nature of pain, 
inconsistencies between diagnostic 
test and patient account leading to 
mistrust
 Stress, lack of satisfaction and 
hostility encountered with some 
patients. 
5 Kennedy, L. 
Binswanger, I. 
Mueller, S, Levy, C. 
Matlock, D. 
Calcaterra, S. Koester, 
S. Frank, J. 
2018 USA Explore primary care providers’ 
experience of discussing and 
implementing opioid tapering 
with patients on long term opioid 
therapy. 




monitoring opioid for 
chronic pain 
Forty primary care providers 
participated in six semi-
structured interviews and 
focus groups. Data was 
analysed using a mixed 
inductive – deductive 
approach. 
Practitioner perspective:
 Discussions of opioid tapering 
emotionally charged and exhausting. 
 Trust compromised when uncertain 
about patient account and when 
enforced tapering 
 Conflict between keeping patients 
satisfied and safely prescribing opioid 
medicines.
6 Desveaux, L. 
Saragosa, M. 
Kithulegoda, N. Ivers, 
M. 
2019 Canada Understand current perspectives 
of family practitioners to opioid 
prescribing and the perceived 
barriers and enablers to 
guideline adherent prescribing
Family practitioners Theoretical domains 
framework. Semi-structured 
interviews with 22 
practitioners. Data coded to 
construct a matrix of how 
individual belief interacts with 
behavioural determinants of 
prescribing opioid medicines. 
Practitioner perspective:
 Challenging conversations around 
opioid prescribing threaten 
therapeutic relationships. 
 Emotional consequences of 
prescribing led to some practitioners 
avoiding prescribing altogether. 
 Tension between managing pain and 
facilitation opioid misuse. 
7 Kennedy, M. Pallotti, 
P. Dickinson, R. 
Harley, C. 




Identify and synthesise 
qualitative literature describing 
the factors influencing the nature 
and extent of opioid prescribing 
by GPs for patients with chronic 
non cancer pain in primary care. 
GPs in primary care Systematic synthesis of 13 
qualitative studies
Practitioner perspective:
 Factors relating to the specific patient, 
the consultation, experiences and 
perceptions of the prescriber will 
influence opioid prescribing decisions. 
 A theoretical framework proposing 
that risk, disagreement and suspicion 
axes interact to shape opioid 
prescribing decisions. 
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STUDIES EXPLORING PATIENT AND PRACTITIONER PERSPECTIVES OF PRESCRIBING OPIOIDS FOR CNCP
No Authors Year Country Aims Population Design / method Key findings
8 Bergman, A. Matthias, 
M. Coffing, J. Krebs, 
E. 
2013 USA Develop a better understanding 
of the respective experiences, 
perceptions, and challenges 
both patients and primary care 
providers face when 
communicating about pain 
management.
Physicians and their 
patients with chronic 
pain. Patients 
prescribed an opioid 
medicine with 6 
collections in the last 
12 months. 
In-depth interviews with 14 
primary care providers and 26 
patients. Inductive thematic 
analysis. 
Patient perspective:
 Importance of being treated as 
individuals. Not being stereotyped and 
receiving depersonalised attention. 
Practitioner perspective: 
 Trust lays the foundation to 
successful pain management, 
especially when opioid therapy is 
involved. 
9 Esquibel, A. Borkan, J 2014 USA Examine patients and physicians 
experience of opioid medicines 
for chronic non-cancer pain and 
the ways in which this influences 
the doctor patient relationship. 
Patients prescribed an 
opioid medicine for 
more than 3 months 
and chronic non-




Narrative approach. In-depth 
interviews with 21 patients and 
their physicians (16 
physicians). Immersion / 
crystallisation process used to 
generate thematic codebook. 
Patient narratives compared to 
physician narratives. 
Patient perspective:
 Perceive reluctance to prescribe 
opioids as lack of empathy
 Patriarchal relationship, patient on 
trial and physician as judge
Practitioner perspective:
 Stigma attached to prescribing opioid 
medicines
 Conflict when there is a difference in 
understanding of pain
 ‘Ideal’ patients are those that align to 
pain management goals. 
STUDIES EXLORING PRACTITIONER and PATIENT TRUST WHEN PRESCRIBING OPIOIDS FOR CNCP
10 Buchman, D. Ho, A. 
Illes, J. 
2016 USA Provide an in-depth examination 
of how trust is negotiated in pain 
management.
Patients with low back 
pain in primary care 
clinics, community 




Grounded theory approach. 27 
semi-structured interviews with 
patients. Data coded and 
organised into themes. Patient 
feedback group to minimise 
researcher misinterpretation. 
Physician feedback group to 
triangulate data and test 
themes. 
Patient perspective:
 Patient trust is threatened if they do 
not experience a degree of 
interpersonal assurance. 
 Patients feel clinicians are being 
untrustworthy of their motives to seek 
treatment and see them as 
untrustworthy informants
Practitioner perspective:
 With opioid medicines practitioner 
saw their role to be as interrogators 
rather than to develop a clinical 
relationship.
11 Sherman, K. Walker, 
R. Saunders, K. 
Shortreed, S. 
Parchman, M. 
Hansen, R. Thakral, 
M. Ludman, E. Dublin, 
S. Von Korff, M. 
2018 USA To compare doctor patient trust 
between clinics where opioid risk 
reduction interventions are being 
implemented and control 
settings where the intervention is 
not being implemented. 
Patients prescribed 
opioid medicines for at 
least 70 days served 
by a health group co-
operative.
Telephone survey of 935 
patient from intervention 
clinics and 653 patients from 
control clinics. Data was 
analysed statistically. 
 82.2% reported trust in their doctors’ 
judgement. (86.3% in control clinics, 
77.9% in intervention clinics)
 88.7% felt doctors trusted them in 
managing opioids. (91.1% in control 
clinic, 86.2% in intervention clinic)
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STUDIES EXPLORING COMMUNICATION BETWEEN PRACTITIONERS AND PRESCRIBERS WHEN PRESCRIBING OPIOIDS FOR CNCP
No Authors Year Country Aims Population Design / method Key findings
12 Matthias, M. Krebs, E. 
Bergman, A. Coffing, 
J. Bair, M. 
2013 USA Improve understanding about 
communication when prescribing 
opioid medicines. Gain an 
insight into how relationships 
between patient and physician 
shape communication about 
opioids. 
Physicians and 
patients in primary 
care clinics. Patients 
were prescribed opioid 
medicines for 
musculoskeletal pain.
5 physicians and 30 patients 
participated. 30 clinic visits 
were audio recorded. 
Individual patient interviews 
after the consultation. 
Immersion / crystallisation 
approach was used to analyse 
the data.  
Patient perspective:
 Some patients believed their doctors 
did not listen to them or care about 
their well-being. 
 Whilst other patients believed doctors 
listened to them and had genuine 
concern for their care. 
13 Henry, S. Bell, R. 
Fenton, J. Kravitz, R. 
2018 USA To understand communication 
between physicians and patient 
about chronic pain and opioids.
Patients and 
physicians at two 
primary care academic 
clinics. Patients were 
prescribed long-term 
opioid medicines for 
chronic 
musculoskeletal pain. 
86 patient clinic consultations 
were videotaped, involving 49 
physicians. Data of patient 
experience and physician visit 
difficulty was also collected. 
Data from consultations was 
coded. Statistical analysis was 
conducted to relate codes to 
patient and physician 
experience. 
 Patient – physician disagreement and 
patient request for opioid dose 
increases were significantly 
associated with worse patient 
experience and physician visit 
difficulty. 
 Visits with patients who reported a 
greater desire for increased pain 
medicine were significantly associated 
with worse patient experience and 
physician visit difficulty. 
14 Matthias, M. Johnson, 
N. Shields, C. Bair, M. 
MacKie, P. Huffman, 
M. Alexander, S. 
2017 USA In depth examination about 
opioid tapering to identify 
communicative challenges and 
best practices. 
Primary care clinics 






prescribed an opioid 
medicine for 
musculoskeletal pain. 
9 primary care physicians and 
37 of their patients 
participated. 95 clinic visits 
were audio recorded. Patients 
and physicians were 
interviewed about patient – 
provider relationship. Data 
was analysed using constant 
comparison. 
 Not all patients felt involved in the 
process and did not understand why 
their doses were being reduced. 
 Where patients think they are doing 
well with their prescribed opioid, 
conversations about tapering can be 
especially difficult. 
 Unsuccessful negotiations about 
tapering led to contention and 
frustration
 Ensure patients do not feel 
abandoned in the process of tapering.
15 Henry, S. Gosdin, M. 
White, A. Kravitz, R. 
2020 USA To identify patient statements to 
opioids that indicates potential 
openness to tapering opioids 
and characterise physician 




pain prescribed a 
long-term opioid. 
86 clinic visits were video 
recorded. Data was analysed 
using coded assessment of 
patient statements and 
reported side effects. 
Assessments were coded as 
positive, negative or 
ambivalent stance towards 
opioids. 
43% of the time physicians did not respond 
to / or had minimal response to clues 
where opioid discontinuation may have 
been explored. 
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STUDIES EXPLORING DECISION MAKING BETWEEN PRACTITIONERS AND PATIENTS WHEN PRESCRIBING OPIOIDS FOR CNCP
No Authors Year Country Aims Population Design / method Key findings
16 Sheilds, C. Fuzzell, L. 
Christ, S. Matthias, M. 
2019 USA Examine primary care provider 
and patient characteristics 
related to discussions of pain 
and opioid management. 
Physicians and 
patients in primary 
care clinics. Patients 
were prescribed opioid 
medicines for 
musculoskeletal pain.
30 patients and 8 primary care 
physicians participated in 
audio recording 78 primary 
care visits. Patients and 
physicians completed 
questionnaires before and 
after their first recorded visit. 
Audio recordings were coded 
to a list of communication 
measures. Statistical analysis 
to relate patient and physician 
characteristics to 
communication.  
 Greater patient pain catastrophizing 
and higher primary care physician 
psychosocial orientation were 
associated with discussion about 
opioid and pain management. 
17 Matthias, M. Talib, T. 
Huffman, M. 
2019 USA To understand treatment 
decision making with patients 
taking opioid medicines. 
Primary care 
physicians in four 
primary care clinics. 




95 clinic visits were audio-
recorded. There were between 
37 patients and 9 physicians. 
Semi-structured interviews 
with 22 patients and 9 
physicians. Constant 
comparison was used to 
analyse the data. 
 Disagreements were rooted in 
perceptions of not being listened to 
and distrust. 
 Refusing to prescribe opioids 
endangered relationship with patient.
 Opioid were prescribed to maintain 
relationship with patients 
 There are limitations on patient input 
into treatment decisions (safety of 
opioids)
 Opioid prescriptions came with rules 
and requirements (urine testing)
 Use prescribing policy to support 
decisions not to prescribe. 
18 Buonora, M. Perez, H. 
Stumph, J. Allen, R. 
Nahvi, S. 
Cummingham, C. 
Merlin, J. Starrels, J. 
2020 USA To describe clinician 
documentation and rationale and 







experienced an opioid 
taper. 
Thematic analysis of 39 
patient records.
 Rationale for taper tended to focus on 
patient behaviours
 Documentation tended to reflect 
practitioner view points, suggesting 
tapers were practitioner initiated.
 Patient disagreement with clinician 
plan was prominent
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STUDIES EXPLORING HOW PROBLEMATIC PRESCRIBING OF OPIOIDS FOR CNCP BECOMES ESTABLISHED
No Authors Year Country Aims Population Design / method Key findings
19 McCrorie, C. Closs, S. 
House, A. Petty, D. 
Ziegler, L. Glidewell, 
L. West, R. Foy, R. 
2015 UK To understand how problematic 
long-term opioid prescribing 
becomes established. 
Patients and GPs 
within GP practices. 
Patients prescribed 
opioid medicines for 
chronic non-cancer 
pain. 
Grounded theory approach. 
Semi-structured interviews 
with 23 patients. Prompts from 
interviews were used to 
facilitate focus group 
discussions with GPs. 
Constant comparison was 
used to analyses data. 
Practitioner perspective:
 Establishing trust was difficult when 
GPs had formed fixed negative 
attitudes towards patients.
 GPs anticipated problematic 
consultations with patients. 
Patient perspective:
 Practitioner explanations about pain 
led to scepticism in patients
STUDIES EXPLORING THE ACCEPTABILITY OF A PAIN MANAGEMENT SERVICE
20 Kesten, J. Thomas, K. 





2020 UK Acceptability (perceived 
appropriateness) of the South 
Gloucestershire pain review 
services.  
Patients and project 
workers at the South 
Gloucestershire pain 
review services.  
Semi-structured interviews 
with 18 patients, 4 GPs, 1 
service manager and 2 project 
workers. Inductive thematic 
analysis of data. 
Patient perspective:
 Patients welcomed non-judgemental 
and encouraging consultations.
 Project workers described as kind and 
good listeners. 
 Patients disliked not being present 
when their case was discussed 
between project worker and GP. 
Practitioner perspective:
 Described importance of forming 
trusting and open relationships
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Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for 
Scoping Reviews (PRISMA-ScR) Checklist
SECTION ITEM PRISMA-ScR CHECKLIST ITEM REPORTED ON PAGE #
TITLE




Provide a structured summary that includes (as 
applicable): background, objectives, eligibility criteria, 
sources of evidence, charting methods, results, and 





Describe the rationale for the review in the context of 
what is already known. Explain why the review 




Provide an explicit statement of the questions and 
objectives being addressed with reference to their key 
elements (e.g., population or participants, concepts, and 
context) or other relevant key elements used to 





Indicate whether a review protocol exists; state if and 
where it can be accessed (e.g., a Web address); and if 




Specify characteristics of the sources of evidence used 
as eligibility criteria (e.g., years considered, language, 




Describe all information sources in the search (e.g., 
databases with dates of coverage and contact with 
authors to identify additional sources), as well as the 
date the most recent search was executed.
6
Search 8
Present the full electronic search strategy for at least 1 






9 State the process for selecting sources of evidence (i.e., screening and eligibility) included in the scoping review. 7
Data charting 
process‡ 10
Describe the methods of charting data from the included 
sources of evidence (e.g., calibrated forms or forms that 
have been tested by the team before their use, and 
whether data charting was done independently or in 
duplicate) and any processes for obtaining and 
confirming data from investigators.
6
Data items 11 List and define all variables for which data were sought and any assumptions and simplifications made. 6




If done, provide a rationale for conducting a critical 
appraisal of included sources of evidence; describe the 
methods used and how this information was used in any 
data synthesis (if appropriate).
Not done
Synthesis of results 13 Describe the methods of handling and summarizing the data that were charted. 6
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Give numbers of sources of evidence screened, 
assessed for eligibility, and included in the review, with 






15 For each source of evidence, present characteristics for which data were charted and provide the citations. Appendix 3
Critical appraisal 
within sources of 
evidence





For each included source of evidence, present the 
relevant data that were charted that relate to the review 
questions and objectives.
Appendix 3




Summarize the main results (including an overview of 
concepts, themes, and types of evidence available), link 
to the review questions and objectives, and consider the 
relevance to key groups.
11
Limitations 20 Discuss the limitations of the scoping review process. 12
Conclusions 21
Provide a general interpretation of the results with 
respect to the review questions and objectives, as well 




Describe sources of funding for the included sources of 
evidence, as well as sources of funding for the scoping 
review. Describe the role of the funders of the scoping 
review.
14
JBI = Joanna Briggs Institute; PRISMA-ScR = Preferred Reporting Items for Systematic reviews and Meta-Analyses 
extension for Scoping Reviews.
* Where sources of evidence (see second footnote) are compiled from, such as bibliographic databases, social media 
platforms, and Web sites.
† A more inclusive/heterogeneous term used to account for the different types of evidence or data sources (e.g., 
quantitative and/or qualitative research, expert opinion, and policy documents) that may be eligible in a scoping 
review as opposed to only studies. This is not to be confused with information sources (see first footnote).
‡ The frameworks by Arksey and O’Malley (6) and Levac and colleagues (7) and the JBI guidance (4, 5) refer to the 
process of data extraction in a scoping review as data charting.
§ The process of systematically examining research evidence to assess its validity, results, and relevance before 
using it to inform a decision. This term is used for items 12 and 19 instead of "risk of bias" (which is more applicable 
to systematic reviews of interventions) to include and acknowledge the various sources of evidence that may be used 
in a scoping review (e.g., quantitative and/or qualitative research, expert opinion, and policy document).
From: Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews 
(PRISMAScR): Checklist and Explanation. Ann Intern Med. 2018;169:467–473. doi: 10.7326/M18-0850.
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